Aug 13, 2020
Strata Oncology Announces Partnership to Broaden Enrollment in Mirati Therapeutics' Clinical Trial of MRTX849, a Novel KRAS G12C Selective Inhibitor
Jun 22, 2020
Imagia Partners with Illumina to Scale Discoveries Across Genomic and Clinical Data
Jun 18, 2020
ArcherDX Enters Collaboration with Bristol Myers Squibb to Apply Personalized Cancer Monitoring (PCM(TM)) to Clinical Research
Jun 16, 2020
IDEAYA and GSK Announce a Broad Partnership in Synthetic Lethality, an Emerging Field in Precision Medicine Oncology
Jun 15, 2020
Global Personalized Medicine Market 2020-2025 - Current Technologies Propelling Market Growth
Jun 09, 2020
Thermo Fisher Scientific to Co-develop a Global Companion Diagnostic for Low-grade Glioma with Agios Pharmaceuticals
Jun 05, 2020
Curesponse Secures $6M Series A for Breakthrough Precision Medicine
Jun 04, 2020
InsightMonk Launches Top 25 Voices Awards in Healthcare Robotics & Precision Medicine Asia
May 29, 2020
PathAI Demonstrates the Potential of AI-based Characterization of the Tumor Microenvironment at ASCO
May 27, 2020
Precision Medicine Industry Assessment 2015-2025: Impact of COVID-19, Trends & Developments, Competitive Landscape
May 27, 2020
CQuentia joins American Heart Association's Center for Health Technology & Innovation Innovators' Network with a focus on Precision Medicine
May 26, 2020
ArcherDX Announces Strategic Collaboration with AstraZeneca to Develop Personalized Cancer Monitoring (PCM) Assays for Minimal Residual Disease (MRD)
May 19, 2020
Rutgers Cancer Institute of New Jersey Joins Caris Life Sciences' Precision Oncology Alliance
May 19, 2020
IDEAYA Biosciences to Participate in Jefferies Virtual Healthcare Conference on Tuesday, June 2, 2020
May 14, 2020
Strata Oncology and Collaborators to Present Data at ASCO 2020 Supporting the Use of StrataNGS to Facilitate a Large-Scale Precision Oncology Program
May 14, 2020
OncoHost to Present Data on Host Response Profiling for Melanoma Patients at 2020 ASCO Annual Meeting
May 13, 2020
The Department of Precision Medicine of Maastricht University Receives 920KEUR from the European Commission to Further Develop Their Work on Artificial Intelligence Tools for COVID-19 Patients
May 13, 2020
In-Vitro Diagnostic (IVD) Markets 2020: Analysis, COVID-19, AI, Companies
May 12, 2020
Pillar Biosciences Closes $29.7 Million in Series C Financing
May 11, 2020
Regeneron and Colorado Center for Personalized Medicine Announce Major New Human Genetics Research Collaboration